Literature DB >> 16597682

Increasing body mass index and obesity in the incident ESRD population.

Holly J Kramer1, Anand Saranathan, Amy Luke, Ramone A Durazo-Arvizu, Cao Guichan, Susan Hou, Richard Cooper.   

Abstract

An increase in obesity prevalence among patients who initiate dialysis may influence the growth of the total ESRD population as a result of improved survival and decreased likelihood for transplantation. Temporal trends in mean body mass index (BMI) and obesity prevalence were examined among incident patients with ESRD by year of dialysis initiation between 1995 and 2002, and these trends were compared with those in the US population during this same period. Among incident dialysis patients, BMI was calculated with the height and estimated dry weight collected from the Centers for Medicare and Medicaid Services End-Stage Renal Disease Medical Evidence Form. In the US population, self-reported height and weight were used. Prevalence of total obesity and obesity stage > or =2 were defined as a BMI > or =30 and > or =35 kg/m(2), respectively. Among incident patients with ESRD, mean BMI increased from 25.7 to 27.5 kg/m(2), and total obesity and obesity stage > or =2 increased by 33 and 63%, respectively, among incident patients with ESRD (P < 0.0001 for obesity trends). BMI slope was approximately two-fold higher in the incident ESRD population compared with the US population for all age groups. However, temporal increases in obesity prevalence were similar between the two populations. As a result of the survival advantage associated with obesity and decreased likelihood for transplantation, these trends most likely will influence the total number of patients who receive dialysis in the next decade.

Entities:  

Mesh:

Year:  2006        PMID: 16597682     DOI: 10.1681/ASN.2005111241

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  86 in total

Review 1.  Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.

Authors:  Rikki M Tanner; Todd M Brown; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  Biliopancreatic diversion in a renal transplant patient.

Authors:  Maite López Deogracias; Agustin Domínguez-Diez; Rosa Palomar-Fontanet; Monica González-Noriega; E Rodrigo; G Fernández-Fresnedo; J A Zubimendi; Francisco Olmedo; Manuel Gómez-Fleitas; M Arias; Carlos Fernández-Escalante
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

3.  Bariatric surgery in a patient on peritoneal dialysis.

Authors:  T H Imam; J Wang; F S Khayat
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

4.  Peritoneal dialysis outcomes in a modern cohort of overweight patients.

Authors:  Shubha Ananthakrishnan; Nigar Sekercioglu; Rosilene M Elias; Joseph Kim; Dimitrios Oreopoulos; Maggie Chu; Joanne M Bargman
Journal:  Int Urol Nephrol       Date:  2013-06-23       Impact factor: 2.370

Review 5.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

6.  Quantifying a rare disease in administrative data: the example of calciphylaxis.

Authors:  Sagar U Nigwekar; Craig A Solid; Elizabeth Ankers; Rajeev Malhotra; William Eggert; Alexander Turchin; Ravi I Thadhani; Charles A Herzog
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

7.  Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity.

Authors:  Akira Mima; Yuzuru Ohshiro; Munehiro Kitada; Motonobu Matsumoto; Pedro Geraldes; Chenzhong Li; Qian Li; Gregory S White; Christopher Cahill; Christian Rask-Madsen; George L King
Journal:  Kidney Int       Date:  2011-01-12       Impact factor: 10.612

8.  Misclassification of obesity in CKD: appearances are deceptive.

Authors:  Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

9.  Obesity and kidney disease: hidden consequences of the epidemic.

Authors:  Csaba P Kovesdy; Susan L Furth; Carmine Zoccali
Journal:  Pediatr Nephrol       Date:  2017-02-01       Impact factor: 3.714

10.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.